EUVIMEDEUVIMED entdecken
EUVIMED · CrossrefZeitschrift

The Breast

ISSN 0960-9776 · Elsevier BV

Neueste Artikel

  1. 8th International consensus guidelines for the management of advanced breast cancer (ABC8 guidelines)

    Fatima Cardoso, Joana Mourato Ribeiro, Eva Schumacher-Wulf, Sandra M. Swain, Shani Paluch-Shimon, Frederique Penault-Llorca, Nancy U. Lin, Prudence A. Francis, Marion Kuper-Hommel, Anne May, Florentine Hilbers, Angel Guerrero, Matti S. Aapro, Rania Azmi, Jyoti Bajpai, Carlos Barrios, Laura Biganzoli, Fran Boyle, Valeria Caceres, Lisa A. Carey, Mariana Chavez-MacGregor, Javier Cortés, Rebecca Dent, Amanda Drury, Nagi S. El Saghir, Hesham Elghazaly, Alexandru Eniu, Lesley Fallowfield, Sandra Ximena Franco Millan, Karen Gelmon, Jenny Gilchrist, Joseph Gligorov, William J. Gradishar, Nadia Harbeck, Xichun Hu, Orit Kaidar-Person, Ranjit Kaur, Belinda Kiely, Sung-Bae Kim, Sarah Kutika Nyagabona

    Erschienen: 2026-12DOI: 10.1016/j.breast.2026.104921

  2. Use of prepectoral polyurethane coated implants in the setting of radiotherapy: the OPBC-09 PRExRT retrospective cohort study

    Florian Fitzal, Rama Kiblawi, Kerstin Wimmer, Florian S. Halbeisen, Gianluca Franceschini, Lorenzo Scardina, Fabio Marazzi, Simona Gipe, Cynthia Kohl, Franziska Trapp, Maja Molska, Oliwia Bednarek, Martin Heidinger, Edvin Ostapenko, Amit Agrawal, Konstantina Balafa, Maggie Banys-Paluchowski, Justin M. Broyles, Oreste D. Gentilini, Maite Goldschmidt, Eduardo González, Martin Haug, Elisabeth A. Kappos, Michael Knauer, Giacomo Montagna, Ira Oikonomou, Martín Rivas Ibarra, Simone Ross-Keck, Dirk J. Schaefer, Andy Schneider, Nicole Speck, Dario Virzi, Mateusz Wichtowski, Artefaa Al-Shamari, Mowid Hamad, André Pfob, Jörg Heil, Lisa Stenman Skarsgård, Christian Korvald, Daniele Passeri

    Erschienen: 2026-12DOI: 10.1016/j.breast.2026.104951

  3. Reirradiation After Repeat Breast Conserving Treatment: Contemporary Evidence, Technical Approaches, and Expert Recommendations

    Dorota Gabryś, Marianne Aznar, Arnaud Beddok, Eric D. Brooks, Dana Casey, J.Isabelle Choi, Stefanie Corradini, Reshma Jagsi, Dana Keilty, Anne Koch, Camilla Kronborg, Marcin Kubeczko, David McClatchy, Philip Poortmans, Marija Popovic, Danielle Rodin, Kilian E. Salerno, Simona F. Shaitelman, Manju Sharma, Yat Tsang, Linda Hong

    Erschienen: 2026-11DOI: 10.1016/j.breast.2026.104955

  4. End-of-life care values and treatment preferences among Japanese breast cancer patients and families: A dyadic cross-sectional study

    Akemi Hara, Ayu Ajitomi, Kazunoshin Tachibana, Kenji Gonda, Masahiro Wada, Rui Omori, Megumi Arai, Kayoko Konuma, Toyoaki Sawano, Yoshiaki Kanemoto, Hirotomo Miyatake, Tomohiro Kurokawa, Yukiko Kouchi, Norio Kanzaki, Yasuhiro Kotera, Yoshitake Takebayashi, Michio Murakami, Tohru Ohtake, Hiroaki Shimmura, Akihiko Ozaki

    Erschienen: 2026-10DOI: 10.1016/j.breast.2026.104899

  5. 24-week home-based walking program in the early adjuvant setting in breast cancer patients who receive aromatase inhibitor endocrine therapy: lessons learned from the SAKK 95/17 WISE prospective, randomized, multicenter trial

    Uwe Güth, Nicolette Hoefnagels, Andreas Müller, Sämi Schär, Laurent Rosset, Mahbiz Nobahar Corke, Michael Schwitter, Andreas Jakob, Cathrin Balmelli, Cornelia Leo, Matthias Fehr, David R. Thorn, Salome Riniker, Amina Chouiter-Djebaili, Jana Musilova, Karin Ribi, Friedemann Honecker

    Erschienen: 2026-08DOI: 10.1016/j.breast.2026.104789

  6. Interplay between HER2-Low status, hormone receptor expression, and therapeutic response to cyclin-dependent kinase 4/6 inhibitors as first-line treatment in luminal-like metastatic breast cancer: The CYCLHER study

    Letizia Pontolillo, Elisabetta Munzone, Paolo Vigneri, Mirco Pistelli, Antonella Palazzo, Nicla La Verde, Marco Mazzotta, Ida Paris, Daniele Alesini, Daniele Santini, Katia Cannita, Armando Orlandi, Emanuela Magnolfi, Laura Giacinti, Mimma Raffaele, Luisa Carbognin, Angela Santoro, Alessandro Rossi, Giorgia Arcuri, Claudia Sangalli, Ornella Garrone, Antonio Mulè, Carmine Valenza, Rossana Berardi, Giampaolo Tortora, Emilio Bria, Giuseppe Curigliano, Diana Giannarelli, Alessandra Fabi

    Erschienen: 2026-08DOI: 10.1016/j.breast.2026.104817

  7. Health-related quality of life and fear of recurrence after early breast cancer treatment: Results from a cross-sectional survey

    Paola Mosconi, Secondo Folli, Rosalba Miceli, Serena Scrudato, Massimiliano Gennaro, Gabriele Tinè, Maria Carmen De Santis, Cristina Ferraris, Gabriele Martelli, Immacolata Di Carlo, Ilaria Maugeri, Alessio Arata, Maria Grazia Carnevale, Chiara Listorti, Roberto Agresti, Claudia Borreani, Claudio Vernieri, Giancarlo Pruneri, Paolo Baili, Valentina Appierto, Serena Di Cosimo, Giovanni Apolone

    Erschienen: 2026-02DOI: 10.1016/j.breast.2025.104647

  8. Concomitant radiation therapy and trastuzumab deruxtecan in metastatic breast cancer: feasibility, safety, and outcomes from a real-life multicentre international cohort

    Luca Visani, Ivica Ratosa, Rupert Bartsch, Barbro Linderholm, Gaia Griguolo, Calogero Saieva, Carlotta Becherini, Marianna Valzano, Viola Salvestrini, Angelika M. Starzer, Peter Kus, Niccolò Bertini, Andrea Rampini, Chiara Mattioli, Domen Ribnikar, Jacopo Nori Cucchiari, Lorenzo Orzalesi, Simonetta Bianchi, Matteo Lambertini, Valentina Guarneri, Lorenzo Livi, Icro Meattini

    Erschienen: 2026-02DOI: 10.1016/j.breast.2026.104691

Jahrgänge

2026 · 1922025 · 7512024 · 1832023 · 6622022 · 1752021 · 5152020 · 2162019 · 7302018 · 2912017 · 7522016 · 1872015 · 7352014 · 2542013 · 3872012 · 2532011 · 5742010 · 1252009 · 3702008 · 1422007 · 3522006 · 1662005 · 2822004 · 1182003 · 2622002 · 1262001 · 1612000 · 811999 · 891998 · 1001997 · 3311996 · 1341995 · 2141994 · 801993 · 1791992 · 154

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.